Abstract

Surgery is no more alone in the scenario of gastric cancer treatment since many years. Although the encouraging results of adjuvant chemotherapy obtained in Japan with S-1 were not achieved in Western countries, a novel approach, after the results of MAGIC trial, published in 2006, has been introduced by means of perioperative, or just preoperative, chemotherapy in the West, with many trials ongoing.

Highlights

  • Radiotherapy has been used from many years until now in the USA, with good results, and is part of many schedules in Europe as well

  • Known as immunological, have been introduced, following gastric cancer molecular genetics studies, which appears to be a new frontier of translational research, as for many other cancers, in order to tailor a specific treatment to each case

  • Similar to that achieved with the management of colorectal and esophageal cancers, multimodal treatment is mandatory, to date, for gastric cancer, but timing, type of therapies, and schedules seem to be a puzzle yet

Read more

Summary

Introduction

Radiotherapy has been used from many years until now in the USA, with good results, and is part of many schedules in Europe as well. Editorial Multimodal Treatment of Gastric Cancer: Surgery, Chemotherapy, Radiotherapy, and Timing Surgery is no more alone in the scenario of gastric cancer treatment since many years.

Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.